B
Brian M. Casey
Researcher at University of Alabama at Birmingham
Publications - 183
Citations - 12220
Brian M. Casey is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Pregnancy & Gestational diabetes. The author has an hindex of 37, co-authored 141 publications receiving 10548 citations. Previous affiliations of Brian M. Casey include National Institutes of Health & University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Mark B. Landon,Catherine Y. Spong,Elizabeth Thom,Marshall W. Carpenter,Susan M. Ramin,Brian M. Casey,Ronald J. Wapner,Michael W. Varner,Dwight J. Rouse,John M. Thorp,Anthony Sciscione,Patrick M. Catalano,Margaret Harper,George R. Saade,Kristine Y. Lain,Yoram Sorokin,Alan M. Peaceman,Jorge E. Tolosa,Garland B. Anderson +18 more
TL;DR: Treatment of mild gestational diabetes mellitus did not significantly reduce the frequency of a composite outcome that included stillbirth or perinatal death and several neonatal complications, but it did reduce the risks of fetal overgrowth, shoulder dystocia, cesarean delivery, and hypertensive disorders.
Journal ArticleDOI
Birth weight in relation to morbidity and mortality among newborn infants.
TL;DR: Mortality and morbidity are increased among infants born at term whose birth weights are at or below the 3rd percentile for their gestational age, and these differences persisted after adjustment for the mother's race and parity and the infant's sex.
Journal ArticleDOI
Subclinical hypothyroidism and pregnancy outcomes.
Brian M. Casey,Jodi S. Dashe,C. Edward Wells,Donald D. McIntire,William Byrd,Kenneth J. Leveno,F. Gary Cunningham +6 more
TL;DR: It is speculated that the previously reported reduction in intelligence quotient of offspring of women with subclinical hypothyroidism may be related to the effects of prematurity.
Journal ArticleDOI
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Mark B. Landon,Catherine Y. Spong,Elizabeth Thom,Marshall W. Carpenter,Susan M. Ramin,Brian M. Casey,Ronald J. Wapner,Michael W. Varner,Dwight J. Rouse,John M. Thorp,Anthony Sciscione,Patrick M. Catalano,Margaret Harper,George R. Saade,Kristine Y. Lain,Yoram Sorokin,Alan M. Peaceman,Jorge E. Tolosa,Garland B. Anderson +18 more
TL;DR: In this paper, the authors show that treatment of mild gestational diabetes mellitus is associated with a reduced risk of several secondary complications including fetal overgrowth, shoulder dystocia, cesarean delivery, and hypertensive disorders.
Journal ArticleDOI
The continuing value of the Apgar score for the assessment of newborn infants.
TL;DR: A retrospective cohort analysis of 151,891 live-born singleton infants without malformations who were delivered at 26 weeks of gestation or later at an inner-city public hospital between January 1988 and December 1998 found that Apgar scores and umbilical-artery blood pH values best predicted neonatal death during the first 28 days after birth.